Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02748099
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GSV | 2-(5-chlorothiophen-2-yl)-N-{(3S)- 1-[3-fluoro-2'-(methylsulfonyl)biphenyl- 4-yl]-2-oxopyrrolidin-3-yl}ethanesulfonamide | A | 2VH6 | 0.72 | |
237 | (2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~- [3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL- 4-YL]-4-METHOXYPYRROLIDINE-1,2- DICARBOXAMIDE | A | 2PR3 | 0.77 | |
744 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)- 1-CYCLOHEXYL-5-OXOPYRROLIDINE-3- CARBOXAMIDE | A | 2H7N | 0.7 | |
FXI | 1-(butyl{[(4-chlorophenyl)amino]carbonyl}amino)- N-[3-fluoro-2'-(methylsulfonyl)biphenyl- 4-yl]cyclopropanecarboxamide | A | 2Q1J | 0.72 | |
2CE | N-[2-(2-CARBAMOYLMETHOXY-ETHOXY)- ETHYL]-2-[2-(4-CHLORO-PHENYLSULFANYL)- ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)- PROPIONAMIDE | H,I | 2BVS | 0.73 | |
478 | {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL- AMINO]-1-BENZYL-2-HYDROXY-PROPYL}- CARBAMIC ACID TETRAHYDRO-FURAN- 3-YL ESTER | B | 1HPV | 0.73 | |
478 | {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL- AMINO]-1-BENZYL-2-HYDROXY-PROPYL}- CARBAMIC ACID TETRAHYDRO-FURAN- 3-YL ESTER | A,B | 1T7J | 0.73 | |
885 | 1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]- L-PROLINE | A,B | 2GC8 | 0.74 | |
A00 | N-[(5S)-5-{[(4-aminophenyl)sulfonyl](isobutyl)amino}- 6-hydroxyhexyl]-Nalpha-(methoxycarbonyl)- beta-phenyl-L-phenylalaninamide | A,B | 2QMP | 0.71 | |
468 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)- 1-CYCLOHEXYL-5-OXOPYRROLIDINE-3- CARBOXAMIDE | A | 2H7P | 0.71 | |
SM1 | N-(BENZYLSULFONYL)-D-SERYL-N-(4- {[AMINO(IMINO)METHYL]AMINO}BENZYL)- L-ALANINAMIDE | U | 1W13 | 0.71 | |
F83 | (3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)- 1,2,3,4-TETRAHYDROISOQUINOLINE- 7-SULFONAMIDE | A,B | 2OBF | 0.72 | |
F83 | (3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)- 1,2,3,4-TETRAHYDROISOQUINOLINE- 7-SULFONAMIDE | A,B | 2G8N | 0.72 | |
I52 | N-{4-[(1-HYDROXYCARBAMOYL-2-METHYL- PROPYL)-(2-MORPHOLIN-4-YL-ETHYL)- SULFAMOYL]-4-PENTYL-BENZAMIDE | A | 1HOV | 0.71 | |
GSK | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-(4-MORPHOLINYL)-2-OXO ETHYL]- 2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE | A | 2CJI | 0.71 | |
AZX | 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO- 2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]- N,N-DIMETHYLBENZAMIDE | A | 2Q8G | 0.7 | |
B22 | [2,2'-{[2-({3-[({2-[4-(AMINOSULFONYL)PHENYL]ETHYL}AMINO)CARBONYL]PHENYL}AMINO)- 2-OXOETHYL]IMINO}DIACETATO(2-)- KAPPAO]COPPER | A | 2FOU | 0.71 | |
TF2 | (N-{4-[(ETHYLANILINO)SULFONYL]- 2-METHYLPHENYL}-3,3,3-TRIFLUORO- 2-HYDROXY-2-METHYLPROPANAMIDE | A | 2BU6 | 0.73 |